Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $0.79-0.00 (0.00%)
ExchangeNASDAQ GS
Volume188,793
Today's Open$0.87
Previous Close$0.79
Data as of 04/18/19 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $0.79 with a 52 week high of $3.69 and a 52 week low of $0.48.
Recent News

April 10, 2019

NantHealth® Showcases Connected Care Benefits to Improve Medical Device Data Collection at the American Nursing Informatics Association (ANIA) Annual Conference

CULVER CITY, Calif. & LAS VEGAS--(BUSINESS WIRE)--Apr. 10, 2019-- NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will present on Connected Care VitalsConX technology at the American Nursing Informatics Association (ANIA) Annual Conference taking place April 12-13, 2019 at the Rio All Suite Hotel & Casino in Las Vegas, NV in booth #213. NantHealth will demonstrate how their ...

Read More >

March 28, 2019

NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results

Total Revenue in Q4 was $22.9 Million SaaS revenue of $17.3 million in Q4, up 9% from Q3 Enhanced efficiencies continued to drive significantly lower operating expenses in both Q4 and full year of 2018 For 2018, substantially improved adjusted Non-GAAP bottom line results Sequencing and Molecular Analysis, 1,021 total tests ordered in Q4, ...

Read More >

March 25, 2019

NantHealth to Report 2018 Fourth-Quarter Financial Results and Host Conference Call on Thursday, March 28

CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 25, 2019-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 fourth quarter on Thursday, March 28, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will...

Read More >

Upcoming Events
There are currently no events scheduled.